Can you review for us the implications of your study on PTEN genomic rearrangements and loss in prostate cancer and the implications for NGS-based profiling in this disease?

Can you review for us the implications of your study on PTEN genomic rearrangements and loss in prostate cancer and the implications for NGS-based profiling in this disease?

Can you review for us the implications of your study on PTEN genomic rearrangements and loss in prostate cancer and the implications for NGS-based profiling in this disease?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Prof. Johann De Bono, MD, PhD

Prof. Johann De Bono, MD, PhD

Professor of Experimental Cancer Medicine
Honorary Consultant Medical Oncologist
Royal Marsden Hospital
Head of the Division of Clinical Studies
Institute of Cancer Research
London, UK